SCHEMBL31038685

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C

nearest known ligand 0.62

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	PTH1R	Q03431	3/20	0.62

▸	GLP1R	P43220	14/20	0.60

▸	RXFP1	Q9HBX9	1/20	0.59

▸	KEAP1	Q14145	1/20	0.58

▸	CCKBR	P32239	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31439252	0.90	PTH1R (0.73)	PTH1RGLP1RRXFP1KEAP1CCKBR
SCHEMBL30376091	0.90	GLP1R (0.74)	GLP1RCCKBR
SCHEMBL29973649	0.90	GLP1R (0.61)	PTH1RGLP1RCCKBR
SCHEMBL31182479	0.89	GLP1R (0.57)	PTH1RGLP1RKEAP1CCKBR
SCHEMBL30576939	0.89	PTH1R (0.65)	PTH1RGLP1RRXFP1KEAP1CCKBR
Dermaseptin S1 SCHEMBL29388838	0.89	GLP1R (0.64)	GLP1RRXFP1KEAP1CCKBR
SCHEMBL31574195	0.88	GLP1R (0.63)	PTH1RGLP1RCCKBR
SCHEMBL30524411	0.88	GLP1R (0.59)	GLP1RRXFP1
SCHEMBL31099255	0.88	GLP1R (0.75)	PTH1RGLP1RKEAP1CCKBR
SCHEMBL30644874	0.87	GLP1R (0.72)	GLP1RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240190938-A1	GIP DERIVATIVES AND USES THEREOF	NOVO NORDISK AS (DK)	2024-06-13	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20240190938-A1	GIP DERIVATIVES AND USES THEREOF	GIPR, GLP1R, GPR119	PTH1R 200/4885GLP1R 2/4885RXFP1 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.